The first exception allows DEA-registered hospitals and clinics to handle controlled substances at their satellite locations as long as certain conditions are met. It also provides flexibility to allow distributors to ship controlled substances directly to satellite locations under certain conditions.
The second exception allows narcotic treatment programs to accept deliveries of narcotics without having to provide a signature at the time of delivery so people don’t have to come into contact as an effort to prevent the spread of COVID-19.
The third exception allows DEA-registered dispensers, including hospitals, pharmacies and physicians, to distribute controlled substances beyond the 5 percent limit — which restricts the number of controlled substances distributed each year — without having to register as a distributor.
More articles on pharmacy:
Death penalty states hoarding drugs needed to ventilate COVID-19 patients
UnitedHealthcare to pay Ohio pharmacists as medical providers
Purdue University grants early graduation to 144 pharmacy students
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
